oxazoles has been researched along with Metastase in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fang, D; Song, Y; Wang, C; Xie, S; Yang, H; Zeng, H; Zhao, Z | 1 |
| Ahmed, AU; Balyasnikova, IV; Burga, R; Castro, B; Cordero, A; Fares, J; Kanojia, D; Lee-Chang, C; Lesniak, MS; Miska, J; Petrosyan, E; Ramsey, MD; Rashidi, A; Schwartz, CW; Xiao, T; Zhang, P | 1 |
| Chen, C; Dai, M; Li, H; Wang, D; Wang, W; Wu, L | 1 |
| Dash, P; Ehrnström, R; Fred Mehrabi, S; Lydrup, ML; Olsson, R; Satapathy, SR; Sjölander, A; Topi, G | 1 |
| Exman, P; Tolaney, SM | 1 |
| Isaacs, C; O'Regan, R; O'Shaughnessy, JA | 1 |
| Bernier, C; Dankner, M; Gravel, M; Park, M; Petrecca, K; Roulston, A; Savage, P; Shore, GC; Siegel, PM; Soliman, A | 1 |
| Han, ME; Jeong, YI; Kang, DH; Kim, DH; Kim, HJ; Kwak, TW; Oh, SO; Shin, HJ | 1 |
| Chen, H; Ding, HF; Dong, Z; Fang, D; Huang, S; Jing, Q; Lu, Y; Su, SB; Yang, L | 1 |
| Ahmed, A; Atula, T; Haglund, C; Hagström, J; Lehtonen, S; Mäkinen, LK; Mäkitie, AA; Salo, T | 1 |
| Chen, C; Harper, MK; Kapadia, A; LaBarbera, DV; Li, Q; Schaack, J; Zhou, Q | 1 |
| Al-Abed, Y; Donia, M; Fagone, P; Maksimovic-Ivanic, D; Mangano, K; McCubrey, JA; Mijatovic, S; Miljkovic, D; Mojic, M; Nicoletti, F; Stankovic, M; Stosic-Grujicic, S; Travali, S; Zocca, MB | 1 |
| Amaya, M; Amirkhosravi, A; Blaydes, S; Desai, H; Francis, JL; Meyer, T; Mousa, SA | 1 |
| Adelman, DC; Bible, K; Heath, EI; Lorusso, PM; Martell, RE | 1 |
| Bodey, G; Fleishman, G; Murphy, WK; Yap, HY | 1 |
| De Gaetano, G; Donati, MB; Mussoni, L; Poggi, A | 1 |
| Ansbacher, R | 1 |
| Bitonti, AJ; Dumont, JA; Jones, WD | 1 |
| Carbone, PP; Davis, TE; Earle, JD; Elson, PJ; Glover, DJ; Hahn, RG; Kvols, LK; Trump, DL; Vogl, SE | 1 |
| Chang, YC; Falkson, G; Knuiman, MW; Pandya, KJ; Skeel, RT; Willson, JK; Wolter, JM | 1 |
| Booth, BW; Budman, D; Ellison, RR; Khojasteh, A; Korzun, AH; Weiss, RB; Wood, W | 1 |
| Adolphson, CC; Ajani, JA; Barlogie, B; Bedikian, AY; Bodey, GP; Korinek, J; Stroehlein, JR | 1 |
| Hanna, MG; Rapp, HJ; Snodgrass, MJ; Zbar, B | 1 |
1 review(s) available for oxazoles and Metastase
| Article | Year |
|---|---|
HER2-positive metastatic breast cancer: a comprehensive review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Bridged-Ring Compounds; Camptothecin; Female; Humans; Immunoconjugates; Neoplasm Metastasis; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab | 2021 |
3 trial(s) available for oxazoles and Metastase
| Article | Year |
|---|---|
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
Topics: Administration, Oral; Adult; Aged; Anemia; Angiogenesis Inhibitors; Area Under Curve; Biological Availability; CDC2-CDC28 Kinases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Oxazoles; Radiotherapy, Adjuvant; Thiazoles; Time Factors; Treatment Outcome | 2008 |
Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Central Nervous System Diseases; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1986 |
Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Brain Diseases; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1986 |
19 other study(ies) available for oxazoles and Metastase
| Article | Year |
|---|---|
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Drug Synergism; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Invasiveness; Neoplasm Metastasis; Oxazoles; Thiazoles; Transcription, Genetic; Tumor Burden; Wound Healing | 2021 |
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer.
Topics: Animals; Antineoplastic Agents, Immunological; Brain Neoplasms; Cell Line, Tumor; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Neural Stem Cells; Oxazoles; Pyridines; Quinazolines; Receptor, ErbB-2; Xenograft Model Antitumor Assays | 2022 |
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclooxygenase Inhibitors; Cytochrome P450 Family 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eicosanoids; Indomethacin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Neovascularization, Pathologic; Oxazoles; PPAR alpha; Pyrimidines; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Estrogen Receptor beta; Female; Genes, APC; HCT116 Cells; HT29 Cells; Humans; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Oxazoles; Receptors, Leukotriene; Signal Transduction; Xenograft Model Antitumor Assays; Zebrafish | 2020 |
Neratinib: an option for HER2-positive metastatic breast cancer.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Disease Management; Female; Fulvestrant; Humans; Neoplasm Metastasis; Oxazoles; Pyridines; Quality of Life; Quinazolines; Quinolines; Receptor, ErbB-2; Trastuzumab | 2020 |
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy.
Topics: Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brain; Cell Line, Tumor; CTLA-4 Antigen; Drug Synergism; Female; Humans; Lactams, Macrocyclic; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Oxazoles; Random Allocation; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma.
Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Humans; Indoles; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Oxazoles; Xenograft Model Antitumor Assays | 2015 |
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; Cell Line, Tumor; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Oncogene Proteins; Ovarian Neoplasms; Oxazoles; RNA, Small Interfering; Thiazoles; Triazoles | 2015 |
Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oxazoles; Squamous Cell Carcinoma of Head and Neck; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 9; Toll-Like Receptors; Tongue Neoplasms | 2016 |
3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen.
Topics: Antineoplastic Agents; Biological Products; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Depsipeptides; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; High-Throughput Screening Assays; Humans; Imidazoles; Models, Biological; Neoplasm Metastasis; Oxazoles; Small Molecule Libraries; Spheroids, Cellular; Vimentin | 2011 |
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.
Topics: Acetates; Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Oxazoles; Saquinavir | 2012 |
Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
Topics: Administration, Oral; Alanine; Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Oxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia | 2003 |
Phase II trial of acivicin in advanced metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Drug Evaluation; Female; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles | 1983 |
Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.
Topics: Animals; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Oxazoles; Platelet Aggregation | 1978 |
Treatment of endometriosis with Danazol.
Topics: Adult; Castration; Endometriosis; Ethisterone; Fallopian Tubes; Female; Humans; Hysterectomy; Isoxazoles; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Oxazoles; Uterine Neoplasms | 1975 |
Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Cell Adhesion; Isoquinolines; Lung Neoplasms; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oxazoles; Oxazolone; Phosphorylation; Piperazines; Protein Kinase C; Pyridines; Staurosporine; Time Factors | 1992 |
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
Topics: Adult; Aged; Alanine; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Isoxazoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxazoles; Thiadiazoles; Vinblastine | 1988 |
Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Isoxazoles; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Metastasis; Oxazoles; Rectal Neoplasms; Vomiting | 1986 |
Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Topics: Animals; BCG Vaccine; Carcinoma, Hepatocellular; Guinea Pigs; Histiocytes; Immunotherapy; Liver Neoplasms; Lymph Nodes; Male; Mycobacterium bovis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Oxazoles; Turpentine | 1972 |